The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


VEPESID 100 mg capsule, soft



CHEPLAPHARM Arzneimittel GmbHPA2239/006/002

Main Information

Trade NameVEPESID 100 mg capsule, soft
Active SubstancesEtoposide
Dosage FormCapsule, soft
Licence HolderCHEPLAPHARM Arzneimittel GmbH
Licence NumberPA2239/006/002

Group Information

ATC CodeL01CB Podophyllotoxin derivatives
L01CB01 etoposide

Status

License statusAuthorised
Licence Issued08/09/1981
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back